Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT04830579 · UNKNOWN
Trial details
- NCT number
- NCT04830579
- Sponsor
- Pharmtechnology LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-10
- Primary completion
- 2021-04-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.